Thank you, I understand your point and it is well taken. When we started the turnaround we knew we had the best optical scanning technology however not having our own telemedicine platform was really a hindrance for scaling the business. If we did not step back and totally redesign our offering so it was a complete end-to-end solution we would be like all our competition. It set MedX back a year and a bit but now we are fully scalable and that is why shareholders have seen the added personnel focused on sales and revenue generation. Our offering now includes the best of breed optical scanner (SIAscope), New HD clinical camera, Patient Management System, PIPEDA, HIPAA,& GDPR secure telemedicine platform. We can track a patient from the time they walk into a pharmacy/Clinic and have a scan taken to when the Dermatologist renders an assessment. This also allows us to monetize our data down the road. Also, we are building our AI engine and that is proving very promising. So lots going on and I believe there will be no more false starts. Thank you